Medsender is a company that offers a comprehensive and EHR-integrated platform to integrate, streamline, and automate communication between providers, patients, and everyone in between. Pulse 2.0 interviewed Medsender founder and co-CEO Zain Qayyum to learn more about the company.
Zain Qayyum’s Background
What is Zain Qayyum’s background? Qayyum said:
“I grew up in New York’s Hudson Valley. My father is a doctor and initially I was in pre-med, too. I started working as a Micro-Biology Researcher at Marist University School of Science in 2012. A year later, I became an intern in the ER of a regional hospital in NY. There I got a glimpse into issues impacting healthcare operations, which was followed by a family member having a disappointing patient experience elsewhere. Feeling there must be a better way, I left pre-med to pursue computer science and find a solution, eventually leading to Medsender’s founding in 2015.”
Formation Of the Company
How did the idea for the company come together? Qayyum shared:
“The seed was planted during that internship when I saw how hospital operations had become so dysfunctional. Right after, my mother encountered a serious health issue, and I ended up traveling between systems that were more than 2.5 hours apart. I’d shuttle documents, medical records, and CD copies, then wait another hour as administrators manually keyed in the data. This prompted me to create a solution and the technology and business evolved from there. As Co-CEO, I oversee the continued technological development of Medsender, now healthcare’s leading workflow automation platform powered by artificial intelligence (AI).”
Core Products
What are the company’s core products and features? Qayyum explained:
“Medsender is the top workflow automation platform for healthcare. It leverages AI to process and synchronize data from unstructured sources like fax, email, and phone, enabling workflows and patient communications to be automated. This streamlines a practice’s operations by handling complex tasks, from processing referrals to scheduling patients. In turn, providers and their staff are freed up to focus on providing the best care and outcomes possible.”
Funding
When asking Qayyum about the company’s funding, he revealed:
“On January 30th, Medsender announced a $5 million Series A investment led by Ballast Point Ventures. We were already in a sound position, running lean and with enough private funding, so we could take the time to find the right partner. Ballast Point shared our vision, understood the issues we were addressing, and agreed our technology could resolve it and scale to meet demand.”
Challenges Faced
What challenges have Qayyum and the team face in building the company? Qayyum acknowledged:
“Finding an ideal funding partner was the foremost concern for us. We spoke with a wide variety of investors, each with a different approach. However, we were fundamentally a health tech company, so we needed a partner who understood medical practice operations and how to scale a SaaS platform. This required a real hybrid, but thankfully, we didn’t have to rush and found exactly what we were looking for in Ballast Point.”
Evolution Of The Company’s Technology
How has the company’s technology evolved since launching? Qayyum noted:
“The initial Medsender platform was introduced in 2018 and provided a secure and reliable digital network to handle the sharing of, and access to, patient information.”
“In 2020, we started integrating deeper with EHRs, and around 2021, we really dug deep into AI. We were able to automate the extracting, labeling, and categorizing of patient data to organize documents, and create and update patient charts in the EHR. At the end of 2024, we launched our human-like AI phone agent, MAIRA, to make sure medical offices didn’t have to worry about picking up the phone every second or making patients wait on hold. Add in user friendliness and we’ve been able to quickly evolve the platform in ways that uniquely support operations.”
Significant Milestones
What have been some of the company’s most significant milestones? Qayyum cited:
“In just four years we scaled to thousands of healthcare provider customers, and every U.S. state is represented. Further, I consider our vision being validated with a $5 million Series A investment a major milestone. Ballast Point Ventures recognized we could overcome a major industry hurdle, meet demand in a capital-efficient way and eliminate a burden that stands in the way of better patient outcomes.”
Customer Success Stories
When asking Qayyum about customer success stories, he highlighted:
“Medsender has many real-world examples showing how customers lowered call handling by up to 80% and workloads by 25%, while saving hundreds of hours monthly via enhanced efficiency. Some recent customer examples include:
– Teter Orthotics and Prosthetics cut 20 hours of manual labor a week, significantly scaled back on paper and now processes more than 60,000 referrals annually with uncanny accuracy.
– Willamette ENT Salem reduced the processing of incoming documents by over 65%, lowering staff workloads for 150 hours of savings per month.
– Frontier Dermatology has seen a 15% boost in scheduling efficiency, eliminating 500 hours monthly.
Readers can view case studies on our site for more examples.”
Total Addressable Market
What total addressable market (TAM) size is the company pursuing? Qayyum assessed:
“According to market research, a clinical workflow solutions market of $15.83 billion will grow at a CAGR of 13.58% to reach approximately $30 billion by 2030. From practices to hospital systems and every entity in between, Medsender serves the entire healthcare spectrum. Additionally, we are in demand by specialist groups in areas as diverse as dermatology and ophthalmology. And, we also count pharmacies, health tech vendors, SMBs, and enterprises as customers. Add in the fact that many medical entities have legacy systems that can’t effectively harness AI, and our addressable market is enormous.”
Differentiation From The Competition
What differentiates the company from its competition? Qayyum affirmed:
“What makes Medsender truly unique is how we use AI to increase cost efficiency and improve the delivery of quality, timely patient care. Roughly 34% of a practice’s budget is consumed by the time, people, and antiquated legacy systems needed to handle admin workloads. With Medsender, operations are no longer a liability — they become an advantage.”
“Our customers enjoy same-day referral processing and can schedule more patients. When using MAIRA, Medsender’s AI phone agent, they can see 80% reductions in call handling. To ensure that the platform is used, we include a robust API and user-friendly interface, supported by existing integrations with dozens of EMR/EHRs and industry apps.”
“Our single platform encompasses the capabilities of many point tools, too. And now, with our market expected to grow considerably, we’ll see a lot of newcomers with unproven technology looking to cash in. In addition to our technology being proven and cost effective, we have deep industry experience, both of which are also strong differentiators for Medsender.”
Future Company Goals
What are some of the company’s future company goals? Qayyum concluded:
“Our priority will be expanding the team across all positions within six months. Technology-wise, we’ll launch MAIRA 2.0 in the next few months, a full-point upgrade of our AI Voice Agent. She’ll sound even more human and provide a new level of user experience that customers will love. Overall, we’ll enhance our AI with powerful, easy-to-use features, including smart automation to speed patient intake, and appointment scheduling and provide insights to improve efficiency and service quality. Naturally, we’ll be laser-focused on generating revenue and scaling customers across the healthcare spectrum, further enabled by key partners like Ballast Point Ventures.”
